Attached files
| file | filename |
|---|---|
| 10-Q - QUARTERLY REPORT - One World Pharma, Inc. | f10q0318_puntogroupcorp.htm |
| EX-31.1 - CERTIFICATION - One World Pharma, Inc. | f10q0318ex31-1_puntogroup.htm |
Exhibit 32.1
CERTIFICATION
PURSUANT TO
18 U.S.C. 1350
(SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002)
I, Lei Wang, Chief Executive Officer and Chief Financial Officer of Punto Group, Corp. (the “Company”), certify, pursuant to 18 U.S.C. Section 1350, that, to the best of my knowledge:
| 1. | the Quarterly Report on Form 10-Q of the Company for the period ended March 31, 2018 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
| 2. | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Dated: May 21, 2018 | By: | /s/ Lei Wang |
Lei Wang Chief
Executive Officer and (Principal
Executive Officer and |
A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.